Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-28 @ 12:03 AM
Study NCT ID:
NCT00634634
Status:
COMPLETED
Last Update Posted:
2023-11-09
First Post:
2008-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Sponsor:
Rutgers, The State University of New Jersey
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-05
First Submit QC Date:
None
Study First Post Date:
2008-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-10-08
Results First Submit QC Date:
None
Results First Post Date:
2023-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-17
Last Update Post Date:
2023-11-09
Last Update Post Date Type:
ACTUAL